These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
807 related articles for article (PubMed ID: 17596566)
21. Sponsorship, authorship and accountability. Davidoff F; DeAngelis CD; Drazen JM; Nicholls MG; Hoey J; Højgaard L; Horton R; Kotzin S; Nylenna M; Overbeke JP; Sox HC; Van der Weyden MB; Wilkes MS Lakartidningen; 2001 Oct; 98(43):4694-6. PubMed ID: 11715244 [No Abstract] [Full Text] [Related]
22. [Partnership between drug industry and the university--innovation, proof of efficacy, drug safety]. Weihrauch TR Z Gastroenterol; 1999 Jul; Suppl 2():12-8. PubMed ID: 10472694 [No Abstract] [Full Text] [Related]
23. Industry funded clinical trials: bias and quality. Del Parigi A Curr Med Res Opin; 2012 Jan; 28(1):23-5. PubMed ID: 22103762 [TBL] [Abstract][Full Text] [Related]
24. Research dishonesty and conflict of interest. Frizelle F N Z Med J; 2002 Dec; 115(1167):U270. PubMed ID: 12552259 [No Abstract] [Full Text] [Related]
26. Biased articles. Friedman JH Med Health R I; 2009 Mar; 92(3):70. PubMed ID: 19385378 [No Abstract] [Full Text] [Related]
27. [ACCOMPLISH and the risks with company sponsored clinical trials]. Furberg C Lakartidningen; 2009 Feb 11-17; 106(7):450. PubMed ID: 19350775 [No Abstract] [Full Text] [Related]
28. [Something for something--physicians, drug industry and general welfare]. Bro F; Olesen F Ugeskr Laeger; 2006 Nov; 168(46):3985. PubMed ID: 17125648 [No Abstract] [Full Text] [Related]
29. [Sponsorship, authorship and accountability]. Davidoff F; DeAngelis CD; Drazen JM; Hoey J; Højgaard L; Horton R; Kotzin S; Nicholls MG; Nylenna M; Overbeke JP; Sox HC; van der Weyden MB; Wilkes MS; Tidsskr Nor Laegeforen; 2001 Sep; 121(21):2531-2. PubMed ID: 11875934 [No Abstract] [Full Text] [Related]
30. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials. Peppercorn J; Blood E; Winer E; Partridge A Cancer; 2007 Apr; 109(7):1239-46. PubMed ID: 17326054 [TBL] [Abstract][Full Text] [Related]
31. Approaches vary for clinical trials in developing countries. Hayasaka E J Natl Cancer Inst; 2005 Oct; 97(19):1401-3. PubMed ID: 16204687 [No Abstract] [Full Text] [Related]
33. How skeptical should we be about industry-sponsored studies? Meador KJ Neurology; 2007 Apr; 68(15):1238; author reply 1238. PubMed ID: 17420417 [No Abstract] [Full Text] [Related]
34. [Openness in the cooperation between physicians and private corporations]. Jørgensen J; Djurhuus JC Ugeskr Laeger; 2003 Apr; 165(16):1642-5. PubMed ID: 12756817 [TBL] [Abstract][Full Text] [Related]
35. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research. Newcombe JP; Kerridge IH Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839 [TBL] [Abstract][Full Text] [Related]
36. Commentary: an independent voice?: conflicts of interest and research on ethical, legal and social issues. Caulfield T Health Law Rev; 2005; 13(2-3):114-6. PubMed ID: 16459424 [No Abstract] [Full Text] [Related]
37. Sponsorship, authorship, and accountability. Landow L N Engl J Med; 2002 Jan; 346(4):290-2. PubMed ID: 11807158 [No Abstract] [Full Text] [Related]